Monashee Investment Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-100,000
Closed -$4.14M 114
2017
Q2
$4.14M Buy
+100,000
New +$3.8M 1.75% 20

Other funds holding RGEN

Monashee Investment Management's RGEN Position: Q3 2017 in Review

Monashee Investment Management sold out of Repligen (RGEN) in Q3 2017, closing a stake of 100,000 shares — an estimated $4.14M sold.

Monashee Investment Management first reported a position in RGEN in Q2 2017 and held it in 1 quarter. The position peaked at $4.14M in Q2 2017. 190 funds tracked by Wall St. Rank hold RGEN as of Q3 2017.

  • Monashee Investment Management reported no remaining Repligen position as of Q3 2017 after selling out during the quarter.
  • Monashee Investment Management sold 100,000 Repligen shares in Q3 2017, an estimated $4.14M.
  • Monashee Investment Management first reported a position in Repligen in Q2 2017 and held it in 1 quarter.
  • Monashee Investment Management's Repligen position peaked at $4.14M in Q2 2017.
  • 190 funds tracked by Wall St. Rank held Repligen as of Q3 2017.

Based on Monashee Investment Management's 13F filing for Q3 2017, filed 13 Nov 2017.